Open | $18.850 |
Close | $18.945 |
Volume / Avg. | 175.450K / 255.116K |
Day Range | 18.630 - 19.280 |
52 Wk Range | 9.260 - 26.700 |
Market Cap | $520.040M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 38 |
Short Interest | 5.43% |
Days to Cover | 6.03 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Castle Biosciences (NASDAQ: CSTL) through any online brokerage.
Other companies in Castle Biosciences’s space includes: Aveanna Healthcare Hldgs (NASDAQ:AVAH), GeneDx Hldgs (NASDAQ:WGS), Prenetics Global (NASDAQ:PRE), Cross Country Healthcare (NASDAQ:CCRN) and Agiliti (NYSE:AGTI).
The latest price target for Castle Biosciences (NASDAQ: CSTL) was reported by Keybanc on Friday, March 1, 2024. The analyst firm set a price target for 28.00 expecting CSTL to rise to within 12 months (a possible 47.80% upside). 16 analyst firms have reported ratings in the last year.
The stock price for Castle Biosciences (NASDAQ: CSTL) is $18.945 last updated March 18, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Castle Biosciences.
Castle Biosciences’s Q1 earnings are confirmed for Wednesday, May 1, 2024.
There is no upcoming split for Castle Biosciences.
Castle Biosciences is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.